Journal article
Bacterial meningitis vaccines: not just for kids
Current infectious disease reports, v 11(4), pp 302-308
Jul 2009
PMID: 19545500
Abstract
Bacterial meningitis remains a feared diagnosis that may lead to significant mortality and morbidity in both the developed and developing world; case fatality rates range from 10% to 50% among all age groups. Several vaccines are available (including the Haemophilus influenzae type B polysaccharide conjugate vaccine) that have proven effective in reducing the incidence of bacterial meningitis. Although a 23-valent pneumococcal polysaccharide vaccine has been available for some time, use of the 7-valent pneumococcal conjugate vaccine (PCV) has demonstrated a dramatic reduction in the incidence of invasive pneumococcal disease; despite the increase in the disease caused by nonvaccine-serotype strains, the success of the 7-valent PCV is noteworthy. A quadrivalent conjugate meningococcal vaccine has been available in the United States since 2005; although its true efficacy remains to be determined, there have been dramatic results with declining incidence in certain high-risk populations and in endemic areas.
Metrics
1 Record Views
3 citations in Scopus
Details
- Title
- Bacterial meningitis vaccines: not just for kids
- Creators
- Renuka Verma - Monmouth Medical CenterMargaret C Fisher
- Publication Details
- Current infectious disease reports, v 11(4), pp 302-308
- Publisher
- Springer Nature
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Scopus ID
- 2-s2.0-67649086106
- Other Identifier
- 991021930427904721